Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1271 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
RSS Create an RSS feed from your search for:
"Perry syndrome" OR "Parkinsonian Disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism
Conditions: Progressive Supranuclear Palsy;   Multi-System Atrophy;   Parkinsonism
Intervention: Drug: [F18]-FDDNP
2 Recruiting Measurement of Gait Using Opal APDM and Gait Mat in Parkinsonism
Condition: Parkinsonism
Interventions: Other: GAITRite;   Other: ADPM
3 Terminated
Has Results
Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism
Conditions: REM Behavior Disorder;   Parkinsonism
Interventions: Drug: Rozerem;   Drug: Placebo
4 Recruiting 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular Parkinsonism
Condition: Vascular Parkinsonism
Intervention: Drug: 18F-DTBZ
5 Unknown  Identification, Prevalence, and Lifespan of Rapid-Onset Dystonia-Parkinsonism
Conditions: Dystonia;   Parkinsonism
Intervention:
6 Recruiting To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
Condition: Hepatic/Cirrhosis Related Parkinsonism.
Intervention: Drug: Lactulose+Rifagut+Bromocriptine
7 Recruiting MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
8 Enrolling by invitation Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Other: no intervention
9 Unknown  Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Parkinsonian Syndrome;   Multiple System Atrophy;   Supranuclear Palsy, Progressive;   Essential Tremor;   Vascular Parkinsonism;   Drug Induced Parkinsonism
Intervention:
10 Unknown  Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
Conditions: Parkinson Disease;   Parkinsonian Disorders
Intervention: Procedure: Biopsy of skin
11 Active, not recruiting Parkinson's Disease, Diagnostic Observations (PADDO)
Conditions: Parkinson's Disease;   Atypical Parkinsonism
Intervention:
12 Enrolling by invitation BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease
Conditions: Parkinsonism, Experimental;   Parkinsonism, Treatment as Usual
Interventions: Behavioral: Body awareness therapy;   Other: Physical therapy
13 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
14 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
15 Completed Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Device: Mobilaser
16 Unknown  Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Conditions: Parkinson Disease;   Parkinsonism;   Seborrheic Dermatitis
Intervention: Drug: Botulinum toxin
17 Active, not recruiting Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Conditions: Progressive Supranuclear Palsy;   Atypical Parkinsonism
Interventions: Drug: Coenzyme Q10;   Drug: CoenzymeQ10
18 Terminated Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Subjects With Schizophrenia (Study P04628)(TERMINATED)
Conditions: Akathisia, Drug-Induced;   Dyskinesia, Drug-Induced;   Parkinsonian Disorders
Interventions: Drug: Preladenant;   Drug: Placebo
19 Enrolling by invitation Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
Conditions: Movement Disorders;   Parkinson Disease;   Parkinsonian Disorders;   Dystonia;   Tourette Syndrome
Intervention: Procedure: Sedation with IV propofol
20 Completed Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders;   Anti-Dyskinesia Agents
Interventions: Drug: AFQ056;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years